PET Imaging in Bladder Cancer: An Update and Future Direction

被引：6

作者：

Zhang-Yin, Jules ^{[1
]}

Girard, Antoine ^{[2
]}

Marchal, Etienne ^{[2
]}

Lebret, Thierry ^{[3
]}

Homo Seban, Marie ^{[4
]}

Uhl, Marine ^{[5
]}

Bertaux, Marc ^{[4
]}

机构：

[1] Dept Nucl Med, Clin Sud Luxembourg, B-6700 Vivalia, Belgium

[2] Amiens Picardy Univ Hosp, Dept Nucl Med, F-80054 Amiens, France

[3] Foch Hosp, Dept Urol, F-92150 Suresnes, France

[4] Foch Hosp, Dept Nucl Med, F-92150 Suresnes, France

[5] Amiens Picardy Univ Hosp, Dept Urol & Renal Transplantat, F-80054 Amiens, France

来源：

PHARMACEUTICALS | 2023年 / 16卷 / 04期

关键词：

positron emission tomography; bladder cancer; 2-[18F]fluoro-2-deoxy-D-glucose; POSITRON-EMISSION-TOMOGRAPHY; DIAGNOSTIC-ACCURACY; RADICAL CYSTECTOMY; PROSTATE-CANCER; ARTIFICIAL-INTELLIGENCE; COMPUTED-TOMOGRAPHY; RESPONSE EVALUATION; F-18-FDG PET/CT; FDG-PET/CT; CHEMOTHERAPY;

D O I：

10.3390/ph16040606

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Molecular imaging with positron emission tomography is a powerful tool in bladder cancer management. In this review, we aim to address the current place of the PET imaging in bladder cancer care and offer perspectives on potential future radiopharmaceutical and technological advancements. A special focus is given to the following: the role of [F-18] 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the clinical management of bladder cancer patients, especially for staging and follow-up; treatment guided by [F-18]FDG PET/CT; the role of [F-18]FDG PET/MRI, the other PET radiopharmaceuticals beyond [F-18]FDG, such as [Ga-68]- or [F-18]-labeled fibroblast activation protein inhibitor; and the application of artificial intelligence.

引用

页数：15

共 82 条

[1] Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data [J].

Abol-Enein, H ;

Bassi, P ;

Boyer, M ;

Coppin, CML ;

Cortesi, E ;

Grossman, HB ;

Hall, RR ;

Horwich, A ;

Malmström, PU ;

Martinez-Piñeiro, JA ;

Sengelov, L ;

Sherif, A ;

Wallace, DMA ;

Bono, AV ;

Goebell, PJ ;

Groshen, S ;

Torti, FM ;

Clarke, NW ;

Roberts, JT ;

Sylvester, R ;

Parmar, MKB ;

Stewart, LA ;

Tierney, JF ;

Vale, CL .

EUROPEAN UROLOGY, 2005, 48 (02) :202-206

[2] Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer [J].

Abrahamsson, Johan ;

Kollberg, Petter ;

Almquist, Helen ;

Blackberg, Mats ;

Brandstedt, Johan ;

Lyttkens, Kerstin ;

Simoulis, Athanasios ;

Sjodahl, Gottfrid ;

Sorenby, Anne ;

Tragardh, Elin ;

Liedberg, Fredrik .

BJU INTERNATIONAL, 2022, 129 (02) :174-181

[3] Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT [J].

Alongi, Pierpaolo ;

Caobelli, Federico ;

Gentile, Roberta ;

Stefano, Alessandro ;

Russo, Giorgio ;

Albano, Domenico ;

Baldari, Sergio ;

Gilardi, Maria Carla ;

Midiri, Massimo .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (02) :224-233

[4] Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer [J].

Apolo, Andrea B. ;

Riches, Jamie ;

Schoeder, Heiko ;

Akin, Oguz ;

Trout, Alisa ;

Milowsky, Matthew I. ;

Bajorin, Dean F. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) :3973-3978

[5] Artificial intelligence in cancer imaging: Clinical challenges and applications [J].

Bi, Wenya Linda ;

Hosny, Ahmed ;

Schabath, Matthew B. ;

Giger, Maryellen L. ;

Birkbak, Nicolai J. ;

Mehrtash, Alireza ;

Allison, Tavis ;

Arnaout, Omar ;

Abbosh, Christopher ;

Dunn, Ian F. ;

Mak, Raymond H. ;

Tamimi, Rulla M. ;

Tempany, Clare M. ;

Swanton, Charles ;

Hoffmann, Udo ;

Schwartz, Lawrence H. ;

Gillies, Robert J. ;

Huang, Raymond Y. ;

Aerts, Hugo J. W. L. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (02) :127-157

[6] Clinical Impact of PET/MR Imaging in Patients with Cancer Undergoing Same-Day PET/CT: Initial Experience in 134 Patients-A Hypothesis-generating Exploratory Study [J].

Catalano, Onofrio A. ;

Rosen, Bruce R. ;

Sahani, Dushyant V. ;

Hahn, Peter F. ;

Guimaraes, Alexander R. ;

Vangel, Mark G. ;

Nicolai, Emanuele ;

Soricelli, Andrea ;

Salvatore, Marco .

RADIOLOGY, 2013, 269 (03) :857-869

[7] Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support [J].

Cha, Kenny H. ;

Hadjiiski, Lubomir M. ;

Cohan, Richard H. ;

Chan, Heang-Ping ;

Caoili, Elaine M. ;

Davenport, Matthew ;

Samala, Ravi K. ;

Weizer, Alon Z. ;

Alva, Ajjai ;

Kirova-Nedyalkova, Galina ;

Shampain, Kimberly ;

Meyer, Nathaniel ;

Barkmeier, Daniel ;

Woolen, Sean ;

Shankar, Prasad R. ;

Francis, Isaac R. ;

Palmbos, Phillip .

ACADEMIC RADIOLOGY, 2019, 26 (09) :1137-1145

[8] Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline [J].

Chang, Sam S. ;

Bochner, Bernard H. ;

Chou, Roger ;

Dreicer, Robert ;

Kamat, Ashish M. ;

Lerner, Seth P. ;

Lotan, Yair ;

Meeks, Joshua J. ;

Michalski, Jeff M. ;

Morgan, Todd M. ;

Quale, Diane Z. ;

Rosenberg, Jonathan E. ;

Zietman, Anthony L. ;

Holzbeierlein, Jeffrey M. .

JOURNAL OF UROLOGY, 2017, 198 (03) :552-559

[9] Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review [J].

Cumberbatch, Marcus G. K. ;

Foerster, Beat ;

Catto, James W. F. ;

Kamat, Ashish M. ;

Kassouf, Wassim ;

Jubber, Ibrahim ;

Shariat, Shahrokh F. ;

Sylvester, Richard J. ;

Gontero, Paolo .

EUROPEAN UROLOGY, 2018, 73 (06) :925-933

[10] Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018 [J].

Cumberbatch, Marcus George Kwesi ;

Jubber, Ibrahim ;

Black, Peter C. ;

Esperto, Francesco ;

Figueroa, Jonine D. ;

Kamat, Ashish M. ;

Kiemeney, Lambertus ;

Lotan, Yair ;

Pang, Karl ;

Silverman, Debra T. ;

Znaor, Ariana ;

Catto, James W. F. .

EUROPEAN UROLOGY, 2018, 74 (06) :784-795

← 1 2 3 4 5 6 7 8 9 →